Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234

Chieko Michikawa, Pedro A. Torres-Saavedra, Natalie L. Silver, Paul M. Harari, Merrill S. Kies, David I. Rosenthal, Quynh Thu Le, Richard C. Jordan, Dzifa Y. Duose, Saradhi Mallampati, Sanchit Trivedi, Rajyalakshmi Luthra, Ignacio I. Wistuba, Abdullah A. Osman, Olivier Lichtarge, Robert L. Foote, Upendra Parvathaneni, D. Neil Hayes, Curtis R. Pickering, Jeffrey N. Myers

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234'. Together they form a unique fingerprint.

Medicine & Life Sciences